Cartazolate

Overview

Cartazolate (SQ 65396) is a pyrazolopyridine modulator with benzodiazepine receptor agonist activity and cyclic AMP phosphodiesterase inhibitory activity. Cartazolate enhances the affinity of 3 H-diazepam for brain-specific binding sites, regulates the GABA/benzodiazepine receptor complex, reversibly increases Na + -independent GABA receptor binding sites, and stimulates the binding of [ 3 H]flunitrazepam to cerebellar membranes. Cartazolate restores punishment-suppressed behavior and exhibits anxiolytic properties. Cartazolate is applicable to anxiety-related research.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Anxiety or Fear-Related Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Phosphodiesterase (PDE) | Products > Signaling Pathways > GABA Receptor

Product Information

• Catalog No.: HY-183471
• CAS No.: 34966-41-1
• Molecular Formula: C15H22N4O2
• Molecular Weight: 290.36
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source